Brief: Cumberland Pharmaceuticals Reports Fourth Quarter Results
26/02/2019 21:18
Feb 26 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS REPORTS FOURTH QUARTER REVENUE
GROWTH
OF 16%
* Q4 ADJUSTED EARNINGS PER SHARE $0.10
* Q4 REVENUE ROSE 16 PERCENT TO $13.5 MILLION
* QTRLY LOSS PER SHARE $0.14
Source text for Eikon: ID:nPn8VbD1qa
Further company coverage: CPIX.O
((Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM